B.S. in Pharmacy, Chung-Ang University College of Pharmacy, Republic of Korea
2015.03 - 2017.02
M.S. in Clinical Pharmacology, Graduate School of Convergence Science and Technology, Seoul National University, Republic of Korea
2017.03 - 2019.08
Ph.D in Clinical Pharmacology, Seoul National University College of Medicine and Hospital, Republic of Korea
2022.03 – Current
Assistant Professor, College of Pharmacy, Daegu Catholic University
2021.09 – 2022.02
Research Assistant Professor, Institute of Biomedical Engineering, Hanyang University College of Medicine
2020.03 – 2022.02
General Manager, Hanyang Medicine-Engineering-Bio Collaborative & Comprehensive Center for drug development
2021.03 – 2021.08
Postdoctoral Research Fellow, Institute of Biomedical Engineering, Hanyang University College of Medicine
2019.09 – 2021.02
Postdoctoral Research Fellow, Seoul National University College of Medicine and Hospital
2015.02 - 2019.08
Research Associate, Seoul National University College of Medicine and Hospital
논문 1
Roh, Y. J., Kim, Y., Lee, J. S., Oh, J. H., Lee, S. M., Yoon, E. L., ... & Jun, D. W. Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease. Life, 2022, 12(11), 1682.
논문 2
Bae J, Kim JE, Perumalsamy H, Park S, Kim Y, Jun DW, Yoon TH: Mass cytometry study on hepatic fibrosis and its drug induced recovery using mouse peripheral blood mononuclear cells. Frontiers in Immunology 2022, 13.
논문 3
Kim, Y., Kim, S., Park, J., & Lee, H.: Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients. Journal of Personalized Medicine 2022, 12(2), 163.
논문 4
Kim Y, Lee S, Kim Y, Jang IJ, Lee S: Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects. Clin Transl Sci 2021.
논문 5
Ban MS, Kim Y, Lee S, Han B, Yu KS, Jang IJ, Chung HK, Lee S: Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean Subjects. Clin Pharmacol Drug Dev 2021.
논문 6
Kim, Y. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life 2021, 11, 250.
논문 7
Kim Y, Kim A, Chung JY: Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation. J Affect Disord 2021, 285:120-126.
논문 8
Hwang, I.; Kim, Y.; Yoo, H.; Jang, I.J.; Yu, K.S.; Lee, S. Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects. Drug Des Devel Ther 2020, 14, 4493 -4502, doi:10.2147/DDDT.S275336.
논문 9
Yoo, H.; Kim, Y.; Jang, I.J.; Yu, K.S.; Lee, S. Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects. Drug Des Devel Ther 2020, 14, 5179 -5187, doi:10.2147/DDDT.S275343.
논문 10
Kim, H.K.; Kang, J.W.; Park, Y.W.; Kim, J.Y.; Kim, M.; Kim, S.J.; Kim, S.M.; Ho Ryu, K.; Yoon, S.; Kim, Y., et al. Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumors. Pharmacol Res Perspect 2020, 8, e00568, doi:10.1002/prp2.568.
논문 11
Kim, Y.; Yoon, S.; Choi, Y.; Yoon, S.H.; Cho, J.Y.; Jang, I.J.; Yu, K.S.; Chung, J.Y. Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects. Sci Rep 2019, 9, 19410, doi:10.1038/s41598-019-55562-4.
논문 12
Kim, Y.; Hatley, O.; Rhee, S.J.; Yi, S.; Lee, H.A.; Yoon, S.; Chung, J.Y.; Yu, K.S.; Lee, H. Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulation. Biopharm Drug Dispos 2019, 40, 135-150, doi:10.1002/bdd.2178.
논문 13
Kim, Y.; Rhee, S.J.; Park, W.B.; Yu, K.S.; Jang, I.J.; Lee, S. A Personalized CYP2C19 Phenotype -Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis. J Clin Med 2019, 8, doi:10.3390/jcm8020227.
논문 14
Yoon, S.; Yi, S.; Rhee, S.J.; Lee, H.A.; Kim, Y.; Yu, K.S.; Chung, J.Y. Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment. Transl Clin Pharmacol 2019, 27, 107-114, doi:10.12793/tcp.2019.27.3.107.
논문 15
Lee, S.; Kim, Y.; Lee, J.J.S.; Im, G.; Cho, J.Y.; Chung, J.Y.; Yoon, S. A pharmacokinetic drug-drug interaction study between pregabalin and tramadol in healthy volunteers. Eur J Clin Pharmacol 2018, 74, 1605 -1613, doi:10.1007/s00228-018-2543-0.
논문 16
Kim, Y.; Kim, A.; Lee, S.; Choi, S.H.; Lee, D.Y.; Song, J.S.; Lee, H.; Jang, I.J.; Yu, K.S. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects. Clin Ther 2017, 39, 1849-1857, doi:10.1016/j.clinthera.2017.08.002.
논문 17
Kim, Y.; Yim, S.; Kim, B.H.; Lee, S. Pharmacokinetic comparison of two formulations of talniflumate 370 mg tablets in healthy Korean volunteers. Int J Clin Pharmacol Ther 2017, 55, 102 -108, doi:10.5414/CP202707.